What the science actually says about HSV-1 and HSV-2: prevalence, transmission, the cross-site recurrence asymmetry, and the immune mechanism behind outbreak frequency reduction.
More than 85 percent of the global adult population is seropositive for HSV-1. In industrial countries, infection rates reach 40 percent by age 12 and continue rising through adulthood. HSV-2 sits at 10 to 20 percent. Lethal complications are rare but real. This post translates t...
HSV-1 prefers the mouth and HSV-2 prefers the genitals, but the site bias has been breaking down for two decades. HSV-1 now causes 40 to 50 percent of new genital herpes infections in young adults. HSV-2 occasionally lands on the lips. The recurrence pattern when the virus is at ...
An HSV-1 outbreak runs through five distinct biological stages, each with a different intervention window. Most people apply the wrong product at the wrong stage, then conclude that nothing works. The actual protocol is more specific than that.
The Labisan dual protocol does not cure HSV-1. No supplement, cream, or pharmaceutical does. What it does is shift the reactivation threshold so the same trigger that used to cause an outbreak no longer crosses the line. This post unpacks the immune mechanism that produces the do...
Most cold sore sufferers know they get outbreaks. Few know which of their three trigger classes (UV, fever, or stress) accounts for which percentage of their personal outbreaks. This 8-week trigger journal is a workbook you keep alongside the Labisan dual protocol. By week 8 you ...
Free shipping over $49 · 30 day money back guarantee
Free shipping over $49 · 30 day money back guarantee
